NeuPath Health, Inc. (NPTH.V)

0.465 -0.01 (-2.11%) CAD  |  TSXV  |  Feb 24, 10:40
More

NeuPath Health Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for NPTH.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Innovotech, Inc. --
Cannara Biotech, Inc. Upgrade
Medexus Pharmaceuticals, Inc. Upgrade
Arch Biopartners, Inc. Upgrade
Biocure Technology, Inc. --

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade